Heart Matters



  Host: Alan S. Brown, MD, FACC, FAHA, FNLA 

  Guest: Maya S. Safarova, MD, PhD, FNLA 


  
    Learn which patients with low-density lipoprotein (LDL) would benefit from this group of medication. In this episode, Dr. Alan Brown is joined by Dr. Maya Safarova, Chief Fellow in the Department of Cardiovascular Medicine at the University of Kansas Medical Center, to discuss the benefits of non-statin LDL lowering therapies. 

Exploring Emerging Non-Statin LDL Lowering Therapies


Identifying Cardiovascular Risk Factors for HIV Patients


Host: Alan S. Brown, MD, FACC, FAHA, FNLA 

  Guest: Maya S. Safarova, MD, PhD, FNLA 


  
    Learn which patients with low-density lipoprotein (LDL) would ben



  Host: Javed Butler, MD <br>

  Guest: Chiadi Ndumele, M.D., Ph.D., M.H.S. <br>


  
    <p>For the first time, the American Heart Association (AHA) has identified cardiovascular-kidney-metabolic (CKM) syndrome, which reflects a strong overlap between heart disease, kidney disease, and obesity. The major clinical consequence of CKM syndrome is multi-organ dysfunction with a particularly high incidence and burden of cardiovascular disease (CVD), and the result of this is premature morbidity and mortality. So as a result, recognizing CKM syndrome is the first step in earlier diagnosis and treatment. Dive into this episode with Dr. Javed Butler who’s joined by Dr. Chiadi Ndumele, Associate Professor of Medicine and the Director of Obesity and Cardiometabolic Research at Johns Hopkins University.</p>